[1]
Miralles-López, J.C. et al. 2022. Analysis of response of severe eosinophilic asthmatic patients to benralizumab. Allergologia et Immunopathologia. 50, 6 (Nov. 2022), 163–168. DOI:https://doi.org/10.15586/aei.v50i6.704.